Accelerate Diagnostics Share Price Today
(NASDAQ: AXDX)

Name: Accelerate Diagnostics Share Price Today (NASDAQ: AXDX) - Accelerate Diagnostics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Accelerate Diagnostics share price is $1.06 & ₹92.19 as on 6 Mar 2025, 2.30 'hrs' IST

$1.06

▲

0.02

(1.92%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Accelerate Diagnostics share price in Dollar and Rupees. Guide to invest in Accelerate Diagnostics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Accelerate Diagnostics, along with analyst recommendations, forecasts, and comprehensive financials.

Accelerate Diagnostics share price movements

Today's Low: $1.04
Today's High: $1.12
$1.06
1.89%
Downside
Day's Volatility :7.14%
Upside
5.36%
52 Weeks Low: $0.73
52 Weeks High: $2.09
$1.06
31.13%
Downside
52 Weeks Volatility :65.07%
Upside
49.28%

Accelerate Diagnostics (AXDX) Returns

Period	Accelerate Diagnostics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-32.48%	3.7%	0.0%
6 Months	-37.28%	-2.8%	0.0%
1 Year	-3.64%	2.5%	0.0%
3 Years	-95.67%	12.9%	-11.6%

Accelerate Diagnostics (AXDX) Key Statistics

in dollars & INR

Previous Close	$1.04
Open	$1.07
Today's High	$1.12
Today's Low	$1.04
Market Capitalization	$26.5M
Today's Volume	$27.2K
52 Week High	$2.09
52 Week Low	$0.73
Revenue TTM	$11.9M
EBITDA	$-34.7M
Earnings Per Share (EPS)	$-2.59
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Accelerate Diagnostics Stock (AXDX) from India?

It is very easy for Indian residents to invest directly in Accelerate Diagnostics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Accelerate Diagnostics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Accelerate Diagnostics or AXDX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Accelerate Diagnostics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Accelerate Diagnostics shares which would translate to 0.820 fractional shares of Accelerate Diagnostics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Accelerate Diagnostics, in just a few clicks!

Returns in Accelerate Diagnostics (AXDX) for Indian investors in Rupees

The Accelerate Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Accelerate Diagnostics investment value today

Current value as on today

₹1,01,312

Returns

₹1,312

(+1.31%)

Returns from Accelerate Diagnostics Stock

₹3,636 (-3.64%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Accelerate Diagnostics (AXDX)

-20%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Accelerate Diagnostics Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Accelerate Diagnostics

Analyst Recommendation on Accelerate Diagnostics

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Accelerate Diagnostics(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Accelerate Diagnostics Stock (AXDX)

What analysts predicted

Upside of 41.51%

Target:

$1.50

Current:

$1.06

Insights on Accelerate Diagnostics Stock (Ticker Symbol: AXDX)

Price Movement
In the last 3 years, AXDX stock has moved down by -95.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 2.98M → 2.97M (in $), with an average decrease of 0.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -11.58M → -14.63M (in $), with an average decrease of 26.3% per quarter
AXDX vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 58.9%
AXDX vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 233.7%
Price to Sales
ForAXDX every $1 of sales, investors are willing to pay $1.8, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

AXDX Accelerate Diagnostics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$5.7M	↑ 35.74%
Net Income	$-88.3M	↑ 40.46%
Net Profit Margin	-1.6K%	↓ 52.35%

	FY19	Y/Y Change
Revenue	$9.3M	↑ 63.97%
Net Income	$-84.3M	↓ 4.55%
Net Profit Margin	-906.8%	↑ 650.98%

	FY20	Y/Y Change
Revenue	$11.2M	↑ 20.09%
Net Income	$-78.2M	↓ 7.23%
Net Profit Margin	-700.47%	↑ 206.33%

	FY21	Y/Y Change
Revenue	$11.8M	↑ 5.53%
Net Income	$-77.7M	↓ 0.65%
Net Profit Margin	-659.5%	↑ 40.97%

	FY22	Y/Y Change
Revenue	$12.8M	↑ 8.23%
Net Income	$-62.5M	↓ 19.57%
Net Profit Margin	-490.06%	↑ 169.44%

	FY23	Y/Y Change
Revenue	$12.1M	↓ 5.43%
Net Income	$-61.6M	↓ 1.4%
Net Profit Margin	-510.97%	↓ 20.91%

	Q2 FY23	Q/Q Change
Revenue	$2.9M	↑ 3.88%
Net Income	$-26.0M	↑ 44.77%
Net Profit Margin	-889.42%	↓ 251.23%

	Q3 FY23	Q/Q Change
Revenue	$3.3M	↑ 12.94%
Net Income	$910.0K	↓ 103.5%
Net Profit Margin	27.58%	↑ 917.0%

	Q4 FY23	Q/Q Change
Revenue	$3.0M	↓ 9.06%
Net Income	$-13.0M	↓ 1528.57%
Net Profit Margin	-433.33%	↓ 460.91%

	Q1 FY24	Q/Q Change
Revenue	$2.9M	↓ 2.63%
Net Income	$-14.2M	↑ 9.46%
Net Profit Margin	-487.16%	↓ 53.83%

	Q2 FY24	Q/Q Change
Revenue	$3.0M	↑ 2.23%
Net Income	$-11.6M	↓ 18.57%
Net Profit Margin	-388.08%	↑ 99.08%

	Q3 FY24	Q/Q Change
Revenue	$3.0M	↓ 0.37%
Net Income	$-14.6M	↑ 26.33%
Net Profit Margin	-492.07%	↓ 103.99%

	FY18	Y/Y Change
Profit	$2.5M	↓ 21.8%

	FY19	Y/Y Change
Profit	$4.4M	↑ 77.2%

	FY20	Y/Y Change
Profit	$4.5M	↑ 1.34%

	FY21	Y/Y Change
Profit	$-381.0K	↓ 108.54%

	FY22	Y/Y Change
Profit	$3.3M	↓ 966.93%

	FY23	Y/Y Change
Profit	$2.6M	↓ 22.8%

	Q2 FY23	Q/Q Change
Profit	$799.0K	↓ 20.97%

	Q3 FY23	Q/Q Change
Profit	$107.0K	↓ 86.61%

	Q4 FY23	Q/Q Change
Profit	$606.0K	↑ 466.36%

	Q1 FY24	Q/Q Change
Profit	$723.0K	↑ 19.31%

	Q2 FY24	Q/Q Change
Profit	$676.0K	↓ 6.5%

	Q3 FY24	Q/Q Change
Profit	$856.0K	↑ 26.63%

	FY18	Y/Y Change
Operating Cash Flow	$-67.8M	↑ 21.54%
Investing Cash Flow	$-20.1M	↓ 21.73%
Financing Cash Flow	$125.8M	↑ 39.09%

	FY19	Y/Y Change
Operating Cash Flow	$-64.8M	↓ 4.37%
Investing Cash Flow	$52.8M	↓ 362.25%
Financing Cash Flow	$6.8M	↓ 94.58%

	FY20	Y/Y Change
Operating Cash Flow	$-50.4M	↓ 22.22%
Investing Cash Flow	$13.6M	↓ 74.24%
Financing Cash Flow	$11.6M	↑ 70.5%

	FY21	Y/Y Change
Operating Cash Flow	$-47.3M	↓ 6.09%
Investing Cash Flow	$8.3M	↓ 38.97%
Financing Cash Flow	$43.2M	↑ 271.58%

	FY22	Y/Y Change
Operating Cash Flow	$-48.7M	↑ 2.97%
Investing Cash Flow	$12.4M	↑ 49.53%
Financing Cash Flow	$31.6M	↓ 26.83%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-10.8M	↓ 19.04%
Investing Cash Flow	$915.0K	↓ 88.85%
Financing Cash Flow	$9.8M	↓ 12835.06%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-8.3M	↓ 23.74%
Investing Cash Flow	$-354.0K	↓ 138.69%
Financing Cash Flow	$-817.0K	↓ 108.33%

Accelerate Diagnostics Technicals Summary

Sell

Neutral

Buy

Accelerate Diagnostics is currently in a neutral trading position according to technical analysis indicators.

Accelerate Diagnostics (AXDX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Accelerate Diagnostics Inc	-19.08%	-37.28%	-3.64%	-95.67%	-99.06%
Medtronic Plc	3.4%	5.22%	9.95%	-11.8%	1.8%
Edwards Lifesciences Corp.	2.13%	10.35%	-17.53%	-32.76%	14.39%
Boston Scientific Corp.	1.13%	28.68%	55.31%	146.09%	207.16%
Stryker Corporation	0.84%	10.53%	11.46%	56.15%	129.21%
Abbott Laboratories	6.67%	21.76%	15.39%	15.86%	78.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Accelerate Diagnostics Inc	NA	NA	-0.55	0.0	0.0	-0.66	NA	-1.95
Medtronic Plc	28.71	28.71	1.91	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.13	31.13	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	84.24	84.24	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.77	50.77	2.91	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Accelerate Diagnostics Inc	Buy	$26.5M	-99.06%	NA	0.0%
Medtronic Plc	Buy	$119.3B	1.8%	28.71	12.83%
Edwards Lifesciences Corp.	Buy	$42.8B	14.39%	31.13	76.75%
Boston Scientific Corp.	Buy	$152.9B	207.16%	84.24	11.07%
Stryker Corporation	Buy	$148.8B	129.21%	50.77	13.25%
Abbott Laboratories	Buy	$238.6B	78.8%	18.34	31.95%

About Accelerate Diagnostics

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Organization	Accelerate Diagnostics
Employees	134
CEO	Mr. Jack Phillips
Industry	Health Technology

Management People of Accelerate Diagnostics

Name	Title
Mr. Jack Phillips	CEO, President & Director
Mr. David Patience	Chief Financial Officer
Mr. Lawrence Michael Mertz	Chief Technology Officer
Ms. Maya Gowri	Senior VP & Head of Operations
Ms. Laura Pierson	Investor Relations Officer
Mr. John Meduri	Chief Strategy Officer
Mr. Chris Thode	Senior Vice President of US Commercial

Important FAQs about investing in AXDX Stock from India :

What is Accelerate Diagnostics share price today?

Accelerate Diagnostics share price today stands at $1.06, Open: $1.07 ; Previous Close: $1.04 ; High: $1.12 ; Low: $1.04 ; 52 Week High: $2.09 ; 52 Week Low: $0.73.

The stock opens at $1.07, after a previous close of $1.04. The stock reached a daily high of $1.12 and a low of $1.04, with a 52-week high of $2.09 and a 52-week low of $0.73.

Can Indians buy Accelerate Diagnostics shares?

Yes, Indians can invest in the Accelerate Diagnostics (AXDX) from India.

With INDmoney, you can buy Accelerate Diagnostics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Accelerate Diagnostics at zero transaction cost.

How can I buy Accelerate Diagnostics shares from India?

It is very easy to buy Accelerate Diagnostics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Accelerate Diagnostics (AXDX) be purchased?

Yes, you can buy fractional shares of Accelerate Diagnostics with INDmoney app.

What are the documents required to start investing in Accelerate Diagnostics stocks?

To start investing in Accelerate Diagnostics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.